BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1846843)

  • 1. Spectrum of mineralocorticoid hypertension.
    Biglieri EG
    Hypertension; 1991 Feb; 17(2):251-61. PubMed ID: 1846843
    [No Abstract]   [Full Text] [Related]  

  • 2. Childhood hypertension due to adrenocortical disorders.
    Oberfield SE; Levine LS; New MI
    Pediatr Ann; 1982 Jul; 11(7):623-6, 628. PubMed ID: 6287390
    [No Abstract]   [Full Text] [Related]  

  • 3. Mineralocorticoid hormones.
    Stockigt JR
    Adv Steroid Biochem Pharmacol; 1976; 5():161-238, 334-5. PubMed ID: 180781
    [No Abstract]   [Full Text] [Related]  

  • 4. An approach to mineralocorticoid hormone hypertension.
    Biglieri EG
    Cardiovasc Clin; 1978; 9(1):91-7. PubMed ID: 667888
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenal mineralocorticoids causing hypertension.
    Biglieri EG; Stockigt JR; Schambelan M
    Am J Med; 1972 May; 52(5):623-32. PubMed ID: 4556934
    [No Abstract]   [Full Text] [Related]  

  • 6. Lessons from licorice.
    Edwards CR
    N Engl J Med; 1991 Oct; 325(17):1242-3. PubMed ID: 1656256
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucocorticoid remediable aldosteronism: a rare hereditary form of adrenocorticotropic hormone regulated mineralocorticoid hypertension.
    Comiter CV; Capelouto CC; Tobin MS; Dluhy RG; Richie JP
    J Urol; 1995 Aug; 154(2 Pt 1):510-2. PubMed ID: 7609119
    [No Abstract]   [Full Text] [Related]  

  • 8. [A precise bioassay for in vivo mineralocorticoid activity in man: relation to plasma aldosterone in normal subjects, essential hypertension, hyperaldosteronism and adrenocortical insufficiency (author transl)].
    Skrabal F
    Wien Klin Wochenschr Suppl; 1977; 78():1-13. PubMed ID: 271428
    [No Abstract]   [Full Text] [Related]  

  • 9. Steroid characteristics of mineralocorticoid adrenocortical hypertension.
    Biglieri EG; Kater CE
    Clin Chem; 1991 Oct; 37(10 Pt 2):1843-8. PubMed ID: 1914200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro glucocorticosteroid and mineralocorticosteroid biosynthesis in Conn's adenoma tissues.
    Bogdan A; Auzéby A; Plouin PF; Touitou Y
    J Endocrinol Invest; 1993 Jan; 16(1):65-8. PubMed ID: 8445158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess.
    Beevers DG; Brown JJ; Ferriss JB; Fraser R; Lever AF; Robertson JI
    Am Heart J; 1973 Sep; 86(3):404-14. PubMed ID: 4592546
    [No Abstract]   [Full Text] [Related]  

  • 12. Licorice-induced hypermineralocorticoidism.
    Farese RV; Biglieri EG; Shackleton CH; Irony I; Gomez-Fontes R
    N Engl J Med; 1991 Oct; 325(17):1223-7. PubMed ID: 1922210
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical aspects of hyper- and hypo-mineralocorticoidism].
    Takeda R
    Nihon Naika Gakkai Zasshi; 1986 Sep; 75(9):1189-203. PubMed ID: 3491864
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mineralocorticoid function of the adrenal cortex under normal conditions and in pathology (review of the literature)].
    Lebedev VP; Vodolazhskaia-Levina EE; Chemidze NP; Khovanskaia MP; Kalashnikova OA
    Vopr Okhr Materin Det; 1971 Feb; 16(2):24-8. PubMed ID: 4933510
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mode of action of mineralocorticoides: their binding with transcortin and cytoselic renal receptors].
    Corvol P; Ulmann A; Ménard J; Michaud A
    J Urol Nephrol (Paris); 1975; 81(4-5):312-9. PubMed ID: 169385
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypertensions caused by hypermineralocorticism].
    Fournier A; Lagrue G
    Sem Hop; 1971 Mar; 47(14):872-89. PubMed ID: 4324368
    [No Abstract]   [Full Text] [Related]  

  • 17. Adrenal minerlocorticoids pathway and its clinical applications.
    Ghulam A; Vantyghem MC; Wemeau JL; Boersma A
    Clin Chim Acta; 2003 Apr; 330(1-2):99-110. PubMed ID: 12636928
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the mechanism of mineralocorticoid-induced hypertension: evidence for the presence of an in-situ mechanism in the arterial wall for a direct action of mineralocorticoids.
    Kornel L
    Clin Biochem; 1981 Oct; 14(5):282-93. PubMed ID: 7037229
    [No Abstract]   [Full Text] [Related]  

  • 19. [Arterial hypertension and mineralocorticoids].
    Molinatti GM; Strumia E
    Folia Endocrinol; 1973 Feb; 26(1):21-48. PubMed ID: 4349746
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypertension with aldosterone excess.
    Brown JJ; Fraser R; Lever AF; Robertson JI
    Br Med J; 1972 May; 2(5810):391-6. PubMed ID: 4554158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.